Studies have shown that neoadjuvant nivolumab may provide long-term benefits for people with non-small cell lung cancer.

Published Date: 17 Feb 2023

BACKGROUND: NSCLC is the most common and important cause of cancer worldwide. Assessment: The patient...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

No Cellphone, Brain Cancer Link; Testosterone Paradox; Breast Density and Cancer

2.

Trump Issues Gag Order for CDC, FDA; Stalled Hearing for RFK Jr.; Sex After Cancer

3.

For elderly, unfit patients, the all-oral AML regimen shows promise.

4.

How a new light-based cancer treatment could destroy tumors without harming healthy cells—using LEDs

5.

Opposition to the Surgical Lymph Node Sampling Rule for Lung Resection.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot